Milestone Pharmaceuticals Investor Relations Material
Latest events
Investor Update
Milestone Pharmaceuticals
Q1 2025
14 May, 2025
Q4 2024
13 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Milestone Pharmaceuticals Inc
Access all reports
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing cardiovascular therapies. The company specializes in the research and development of treatments for episodic cardiovascular conditions, aiming to provide rapid and effective symptom relief. Its lead drug candidates target conditions such as paroxysmal supraventricular tachycardia (PSVT) and other heart-related disorders. The company is headquartered in Montreal, Canada, and its shares are listed on the NASDAQ.
Key slides for Milestone Pharmaceuticals Inc
TD Cowen 45th Annual Healthcare Conference
Milestone Pharmaceuticals Inc
TD Cowen 45th Annual Healthcare Conference
Milestone Pharmaceuticals Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
MIST
Country
🇨🇦 Canada